Briel, Matthias

GRADE equity guidelines 2: considering health equity in GRADE guideline development: equity extension of the guideline development checklist

Akl, E. A., Welch, V., Pottie, K., Eslava-Schmalbach, J., Darzi, A., Sola, I., Katikireddi, S. V., Singh, J., Murad, M. H., Meerpohl, J., et al. (2017) · Journal of Clinical Epidemiology

Clinical practice guidelines implementationCultural Competency in Health Care

Cited by 79

Systematic reviews experience major limitations in reporting absolute effects

Alonso-Coello, P., Carrasco-Labra, A., Brignardello-Petersen, R., Neumann, I., Akl, E. A., Vernooij, R. W. M., Johnston, B. C., Sun, X., Briel, M., Busse, J. W., et al. (2016) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsClinical practice guidelines implementation

Cited by 70

Nonregistration, discontinuation, and nonpublication of randomized trials: A repeated metaresearch analysis

Speich, B., Gryaznov, D., Busse, J. W., Gloy, V. L., Lohner, S., Klatte, K., Taji Heravi, A., Ghosh, N., Lee, H., Mansouri, A., et al. (2022) · PLOS Medicine

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 69

Development of ROBUST-RCT: Risk Of Bias instrument for Use in SysTematic reviews-for Randomised Controlled Trials

Wang, Y., Keitz, S., Briel, M., Glasziou, P., Brignardello-Petersen, R., Siemieniuk, R. A. C., Zeraatkar, D., Akl, E. A., Armijo-Olivo, S., Bassler, D., et al. (2025) · BMJ

Meta-analysis and systematic reviewsDelphi Technique in Research

Cited by 60

Compelling evidence from meta-epidemiological studies demonstrates overestimation of effects in randomized trials that fail to optimize randomization and blind patients and outcome assessors

Wang, Y., Parpia, S., Couban, R., Wang, Q., Armijo-Olivo, S., Bassler, D., Briel, M., Brignardello-Petersen, R., Gluud, L. L., Keitz, S. A., et al. (2024) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 58

Methods for detecting, quantifying, and adjusting for dissemination bias in meta-analysis are described

Mueller, K. F., Meerpohl, J. J., Briel, M., Antes, G., von Elm, E., Lang, B., Motschall, E., Schwarzer, G., & Bassler, D. (2016) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsStatistical Methods in Epidemiology

Cited by 48

Reminding Peer Reviewers of Reporting Guideline Items to Improve Completeness in Published Articles: Primary Results of 2 Randomized Trials

Speich, B., Mann, E., Schönenberger, C. M., Mellor, K., Griessbach, A. N., Dhiman, P., Gandhi, P., Lohner, S., Agarwal, A., Odutayo, A., et al. (2023) · JAMA Network Open

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 41

Prospective analysis of adrenal function in patients with acute exacerbations of COPD: the reduction in the use of corticosteroids in exacerbated COPD (REDUCE) trial

Schuetz, P., Leuppi, J. D., Bingisser, R., Bodmer, M., Briel, M., Drescher, T., Duerring, U., Henzen, C., Leibbrandt, Y., Maier, S., et al. (2015) · European Journal of Endocrinology

Adrenal Hormones and DisordersChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 35

Impact of a short version of the CONSORT checklist for peer reviewers to improve the reporting of randomised controlled trials published in biomedical journals: study protocol for a randomised controlled trial

Speich, B., Schroter, S., Briel, M., Moher, D., Puebla, I., Clark, A., Maia Schlüssel, M., Ravaud, P., Boutron, I., & Hopewell, S. (2020) · BMJ Open

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 35

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials

Kasenda, B., von Elm, E., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., et al. (2016) · PLOS Medicine

Pharmaceutical industry and healthcareAcademic integrity and plagiarism

Cited by 33

Randomized Trials Stopped Early for Benefit: A Systematic Review

Montori, V. M., Devereaux, P. J., Adhikari, N. K. J., Burns, K. E. A., Eggert, C. H., Briel, M., Lacchetti, C., Leung, T. W., Darling, E., Bryant, D. M., et al. (2005) · JAMA

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 26

Reporting quality of clinical trial protocols: a repeated cross-sectional study about the Adherence to SPIrit Recommendations in Switzerland, CAnada and GErmany (ASPIRE-SCAGE)

Gryaznov, D., von Niederhäusern, B., Speich, B., Kasenda, B., Ojeda-Ruiz, E., Blümle, A., Schandelmaier, S., Mertz, D., Odutayo, A., Tomonaga, Y., et al. (2022) · BMJ Open

Meta-analysis and systematic reviewsStatistical Methods in Clinical Trials

Cited by 22

A longitudinal assessment of trial protocols approved by research ethics committees: The Adherance to SPIrit REcommendations in the UK (ASPIRE-UK) study

Speich, B., Odutayo, A., Peckham, N., Ooms, A., Stokes, J. R., Saccilotto, R., Gryaznov, D., von Niederhäusern, B., Copsey, B., Altman, D. G., et al. (2022) · Trials

Meta-analysis and systematic reviewsPharmaceutical industry and healthcare

Cited by 21

A meta-research study of randomized controlled trials found infrequent and delayed availability of protocols

Schönenberger, C. M., Griessbach, A., Taji Heravi, A., Gryaznov, D., Gloy, V. L., Lohner, S., Klatte, K., Ghosh, N., Lee, H., Mansouri, A., et al. (2022) · Journal of Clinical Epidemiology

Meta-analysis and systematic reviewsAcademic Publishing and Open Access

Cited by 17

Evaluation of Planned Subgroup Analysis in Protocols of Randomized Clinical Trials

Taji Heravi, A., Gryaznov, D., Schandelmaier, S., Kasenda, B., Briel, M., Adherence to SPIRIT Recommendations (ASPIRE) Study Group, von Niederhäusern, B., Speich, B., Ojeda-Ruiz, E., Blümle, A., et al. (2021) · JAMA Network Open

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 5